2,861
Views
8
CrossRef citations to date
0
Altmetric
HPV

Willingness to get HPV vaccination among female university students in Kuwait and its relation to vaccine conspiracy beliefs

ORCID Icon, ORCID Icon & ORCID Icon
Article: 2194772 | Received 10 Feb 2023, Accepted 18 Mar 2023, Published online: 02 Apr 2023

References

  • Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, Jin T. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Front Public Health. 2020;8:552028. doi:10.3389/fpubh.2020.552028.
  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: gLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–10. doi:10.3322/caac.21660.
  • Zhao M, Wu Q, Hao Y, Hu J, Gao Y, Zhou S, Han L. Global, regional, and national burden of cervical cancer for 195 countries and territories, 2007–2017: findings from the global burden of disease study 2017. BMC Womens Health. 2021;21:419. doi:10.1186/s12905-021-01571-3.
  • Boda D, Docea AO, Calina D, Ilie MA, Caruntu C, Zurac S, Neagu M, Constantin C, Branisteanu D, Voiculescu V, et al. Human papilloma virus: apprehending the link with carcinogenesis and unveiling new research avenues (Review). Int J Oncol. 2018;52:637–55. doi:10.3892/ijo.2018.4256.
  • Gravitt PE, Winer RL. Natural history of HPV infection across the lifespan: role of Viral Latency. Viruses. 2017;9:267. doi:10.3390/v9100267.
  • Christensen ND. HPV disease transmission protection and control. Microb Cell. 2016;3:476–90. doi:10.15698/mic2016.09.530.
  • Egawa N, Egawa K, Griffin H, Doorbar J. Human papillomaviruses; epithelial tropisms, and the development of Neoplasia. Viruses. 2015;7:3863–90. doi:10.3390/v7072802.
  • Petca A, Borislavschi A, Zvanca ME, Petca RC, Sandru F, Dumitrascu MC. Non-sexual HPV transmission and role of vaccination for a better future (review). Exp Ther Med. 2020;20:186. doi:10.3892/etm.2020.9316.
  • Panatto D, Amicizia D, Trucchi C, Casabona F, Lai PL, Bonanni P, Boccalini S, Bechini A, Tiscione E, Zotti CM, et al. Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies. BMC Public Health. 2012;12:623. doi:10.1186/1471-2458-12-623.
  • Lehoux M, D’abramo CM, Archambault J. Molecular mechanisms of human papillomavirus-induced carcinogenesis. Public Health Genomics. 2009;12:268–80. doi:10.1159/000214918.
  • Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A. Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination-review of current perspectives. J Oncol. 2019;2019:3257939. doi:10.1155/2019/3257939.
  • World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. [accessed 2023 Feb 9]. https://www.who.int/publications/i/item/9789240014107.
  • Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, Burger EA, Martin D, Nguyen DTN, Bénard É, et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395:591–603. doi:10.1016/s0140-6736(20)30157-4.
  • Wang R, Pan W, Jin L, Huang W, Li Y, Wu D, Gao C, Ma D, Liao S. Human papillomavirus vaccine against cervical cancer: opportunity and challenge. Cancer Lett. 2020;471:88–102. doi:10.1016/j.canlet.2019.11.039.
  • Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2019;68:698–702. doi:10.15585/mmwr.mm6832a3.
  • Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination - updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2016;65:1405–8. doi:10.15585/mmwr.mm6549a5.
  • Soliman M, Oredein O, Dass CR. Update on safety and efficacy of HPV vaccines: focus on gardasil. Int J Mol Cell Med. 2021;10:101–13. doi:10.22088/ijmcm.Bums.10.2.101.
  • Arbyn M, Xu L. Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials. Expert Rev Vaccines. 2018;17:1085–91. doi:10.1080/14760584.2018.1548282.
  • Porras C, Tsang SH, Herrero R, Guillén D, Darragh TM, Stoler MH, Hildesheim A, Wagner S, Boland J, Lowy DR, et al. Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica vaccine trial. Lancet Oncol. 2020;21:1643–52. doi:10.1016/s1470-2045(20)30524-6.
  • Al-Awadhi R, Chehadeh W, Kapila K. Prevalence of human papillomavirus among women with normal cervical cytology in Kuwait. J Med Virol. 2011;83:453–60. doi:10.1002/jmv.21981.
  • Al-Awadhi R, Chehadeh W, Jaragh M, Al-Shaheen A, Sharma P, Kapila K. Distribution of human papillomavirus among women with abnormal cervical cytology in Kuwait. Diagn Cytopathol. 2013;41:107–14. doi:10.1002/dc.21778.
  • Sallam M, Al-Mahzoum K, Eid H, Assaf AM, Abdaljaleel M, Al-Abbadi M, Mahafzah A. Attitude towards HPV vaccination and the intention to get vaccinated among female university students in health schools in Jordan. Vaccines (Basel). 2021;9:1432. doi:10.3390/vaccines9121432.
  • Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. Vaccine. 2014;32:2150–9. doi:10.1016/j.vaccine.2014.01.081.
  • Bencherit D, Kidar R, Otmani S, Sallam M, Samara K, Barqawi HJ, Lounis M. Knowledge and awareness of Algerian students about cervical cancer, HPV and HPV vaccines: a cross-sectional study. Vaccines (Basel). 2022;10:1420. doi:10.3390/vaccines10091420.
  • Fernandes Q, Allouch S, Gupta I, Elmakaty I, Elzawawi KE, Amarah A, Al-Thawadi H, Al-Farsi H, Vranic S, Al Moustafa A-E. Human papillomaviruses-related cancers: an update on the presence and prevention strategies in the Middle East and North African regions. Pathogens. 2022;11:1380. doi:10.3390/pathogens11111380.
  • Sallam M, Al-Fraihat E, Dababseh D, Yaseen A, Taim D, Zabadi S, Hamdan AA, Hassona Y, Mahafzah A, Şahin GÖ. Dental students’ awareness and attitudes toward HPV-related oral cancer: a cross sectional study at the university of Jordan. BMC Oral Health. 2019;19:171. doi:10.1186/s12903-019-0864-8.
  • Sallam M, Dababseh D, Yaseen A, Al-Haidar A, Ettarras H, Jaafreh D, Hasan H, Al‐salahat K, Al‐fraihat E, Hassona Y, et al. Lack of knowledge regarding HPV and its relation to oropharyngeal cancer among medical students. Cancer Rep (Hoboken). 2022;5:e1517. doi:10.1002/cnr2.1517.
  • Alsous MM, Ali AA, Al-Azzam SI, Abdel Jalil MH, Al-Obaidi HJ, Al-Abbadi EI, Hussain ZK, Jirjees FJ. Knowledge and awareness about human papillomavirus infection and its vaccination among women in Arab communities. Sci Rep. 2021;11:786. doi:10.1038/s41598-020-80834-9.
  • Rezqalla J, Alshatti M, Ibraheem A, Omar D, Houda AF, AlHaqqan S, AlGhurair S, Akhtar S. Human papillomavirus (HPV): unawareness of the causal role of HPV infection in cervical cancer, HPV vaccine availability, and HPV vaccine uptake among female school teachers in a Middle Eastern country. J Infect Public Health. 2021;14:661–7. doi:10.1016/j.jiph.2021.01.015.
  • Albanghali MA, Othman BA. A cross-sectional study on the knowledge of sexually transmitted diseases among young adults living in Al Bahah, Saudi Arabia. Int J Environ Res Public Health. 2020;17:1872. doi:10.3390/ijerph17061872.
  • Horanieh N, Macdowall W, Wellings K. How should school-based sex education be provided for adolescents in Saudi Arabia? Views of stakeholders. Sex Educ. 2021;21:645–59. doi:10.1080/14681811.2020.1843424.
  • Bruni L, Albero G, Serrano B, Mena M, Collado J, Gómez D, Muñoz, J, Bosch, F, de Sanjosé, S. Human Papillomavirus and Related Diseases in Kuwait. Summary Report. [accessed 2023 Feb 9]. https://hpvcentre.net/statistics/reports/KWT.pdf.
  • Milondzo T, Meyer JC, Dochez C, Burnett RJ. Human papillomavirus vaccine hesitancy highly evident among caregivers of girls attending South African private schools. Vaccines (Basel). 2022;10:503. doi:10.3390/vaccines10040503.
  • Sallam M, Dababseh D, Eid H, Al-Mahzoum K, Al-Haidar A, Taim D, Yaseen A, Ababneh NA, Bakri FG, Mahafzah A. High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: a study in Jordan and Kuwait among other Arab countries. Vaccines (Basel). 2021;9:42. doi:10.3390/vaccines9010042.
  • Al-Sanafi M, Sallam M. Psychological determinants of COVID-19 vaccine acceptance among healthcare workers in Kuwait: a cross-sectional study using the 5C and vaccine conspiracy beliefs scales. Vaccines (Basel). 2021;9:701. doi:10.3390/vaccines9070701.
  • Alsanafi M, Al-Mahzoum K, Sallam M. Monkeypox knowledge and confidence in diagnosis and management with evaluation of emerging virus infection conspiracies among health professionals in Kuwait. Pathogens. 2022;11:994. doi:10.3390/pathogens11090994.
  • Milondzo T, Meyer JC, Dochez C, Burnett RJ. Misinformation drives low human papillomavirus vaccination coverage in South African girls attending private schools. Front Public Health. 2021;9:598625. doi:10.3389/fpubh.2021.598625.
  • Kuwait University. About Kuwait University. [accessed 2023 Feb 9]. http://kuweb.ku.edu.kw/ku/ar/AboutUniversity/AboutKU/AboutUSKU/index.htm.
  • Shapiro GK, Holding A, Perez S, Amsel R, Rosberger Z. Validation of the vaccine conspiracy beliefs scale. Papillomavirus Res. 2016;2:167–72. doi:10.1016/j.pvr.2016.09.001.
  • Dany M, Chidiac A, Nassar AH. Human papillomavirus vaccination: assessing knowledge, attitudes, and intentions of college female students in Lebanon, a developing country. Vaccine. 2015;33:1001–7. doi:10.1016/j.vaccine.2015.01.009.
  • Abou El-Ola MJ, Rajab MA, Abdallah DI, Fawaz IA, Awad LS, Tamim HM, Ibrahim A, Mugharbil A, Moghnieh R. Low rate of human papillomavirus vaccination among schoolgirls in Lebanon: barriers to vaccination with a focus on mothers’ knowledge about available vaccines. Ther Clin Risk Manag. 2018;14:617–26. doi:10.2147/tcrm.S152737.
  • Al Shdefat S, Al Awar S, Osman N, Khair H, Sallam G, Maki S. Identification level of awareness and knowledge of Emirati men about HPV. J Healthc Eng. 2022;2022:5340064. doi:10.1155/2022/5340064.
  • Haddad SF, Kerbage A, Eid R, Kourie HR. Awareness about the human papillomavirus (HPV) and HPV vaccine among medical students in Lebanon. J Med Virol. 2022;94:2796–801. doi:10.1002/jmv.27509.
  • Abi Jaoude J, Khair D, Dagher H, Saad H, Cherfan P, Kaafarani MA, Jamaluddine Z, Ghattas H. Factors associated with human papilloma virus (HPV) vaccine recommendation by physicians in Lebanon, a cross-sectional study. Vaccine. 2018;36:7562–7. doi:10.1016/j.vaccine.2018.10.065.
  • Abi Jaoude J, Saad H, Farha L, Dagher H, Khair D, Kaafarani MA, Jamaluddine Z, Cherfan P. Barriers, attitudes and clinical approach of Lebanese physicians towards HPV vaccination; a cross- sectional study. Asian Pac J Cancer Prev. 2019;20:3181–7. doi:10.31557/apjcp.2019.20.10.3181.
  • Hamdi S. The impact of teachings on sexuality in Islam on HPV vaccine acceptability in the Middle East and North Africa region. J Epidemiol Glob Health. 2018;7(Suppl S1):S17–s22. doi:10.1016/j.jegh.2018.02.003.
  • Farsi NJ, Baharoon AH, Jiffri AE, Marzouki HZ, Merdad MA, Merdad LA. Human papillomavirus knowledge and vaccine acceptability among male medical students in Saudi Arabia. Hum Vaccin Immunother. 2021;17:1968–74. doi:10.1080/21645515.2020.1856597.
  • Obeid DA, Almatrrouk SA, Alfageeh MB, Al-Ahdal MNA, Alhamlan FS. Human papillomavirus epidemiology in populations with normal or abnormal cervical cytology or cervical cancer in the Middle East and North Africa: a systematic review and meta-analysis. J Infect Public Health. 2020;13:1304–13. doi:10.1016/j.jiph.2020.06.012.
  • Dochez C, Al Awaidy S, Mohsni E, Fahmy K, Bouskraoui M. Strengthening national teams of experts to support HPV vaccine introduction in Eastern Mediterranean countries: lessons learnt and recommendations from an international workshop. Vaccine. 2020;38:1114–19. doi:10.1016/j.vaccine.2019.11.027.
  • Abdullahi LH, Hussey GD, Wiysonge CS, Kagina BM. Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: stakeholders’ perspectives. S Afr Med J. 2020;110:525–31. doi:10.7196/SAMJ.2020.v110i6.14332.
  • Gamaoun R. Knowledge, awareness and acceptability of anti-HPV vaccine in the Arab states of the Middle East and North Africa region: a systematic review. East Mediterr Health J. 2018;24:538–48. doi:10.26719/2018.24.6.538.
  • Huang Y, Chen C, Wang L, Wu H, Chen T, Zhang L. HPV vaccine hesitancy and influencing factors among university students in China: a cross-sectional survey based on the 3cs model. Int J Environ Res Public Health. 2022;19:14025. doi:10.3390/ijerph192114025.
  • Van Boetzelaer E, Daae A, Winje BA, Vestrheim DF, Steens A, Stefanoff P. Sociodemographic determinants of catch-up HPV vaccination completion between 2016-2019 in Norway. Hum Vaccin Immunother. 2022;18:1976035. doi:10.1080/21645515.2021.1976035.
  • Sidiropoulou M, Gerogianni G, Kourti FE, Pappa D, Zartaloudi A, Koutelekos I, Dousis E, Margari N, Mangoulia P, Ferentinou E, et al. Perceptions, knowledge and attitudes among young adults about prevention of HPV infection and immunization. Healthcare (Basel). 2022;10:1721. doi:10.3390/healthcare10091721.
  • Ortashi O, Raheel H, Shalal M. Acceptability of human papilloma virus vaccination among women in the United Arab Emirates. Asian Pac J Cancer Prev. 2014;15:2007–11. doi:10.7314/apjcp.2014.15.5.2007.
  • Abu-Raddad LJ, Ghanem KG, Feizzadeh A, Setayesh H, Calleja JM, Riedner G. HIV and other sexually transmitted infection research in the Middle East and North Africa: promising progress? Sex Transm Infect. 2013;89(Suppl S3):iii1–4. doi:10.1136/sextrans-2013-051373.
  • Mallik MK, Alramadhan B, Dashti H, Al-Shaheen A, Al Juwaiser A, Das DK, George SS, Kapila K. Human papillomaviruses other than 16, 18 and 45 are the major high risk HPV genotypes amongst women with abnormal cervical smear cytology residing in Kuwait: implications for future vaccination strategies. Diagn Cytopathol. 2018;46:1036–9. doi:10.1002/dc.24035.
  • Kapila K, Balakrishnan M, Ali RH, Al-Juwaiser A, George SS, Mallik MK. Interpreting a diagnosis of atypical squamous cells of undetermined significance in cervical cytology and its association with human papillomavirus: a retrospective analysis of 180 cases in Kuwait. Sultan Qaboos Univ Med J. 2020;20:e318–23. doi:10.18295/squmj.2020.20.04.007.
  • World Health Organization. Human papillomavirus vaccines: wHO position paper, October 2014-recommendations. Vaccine. 2015;33:4383–4. doi:10.1016/j.vaccine.2014.12.002.
  • Barnard M, Cole AC, Ward L, Gravlee E, Cole ML, Compretta C. Interventions to increase uptake of the human papillomavirus vaccine in unvaccinated college students: a systematic literature review. Prev Med Rep. 2019;14:100884. doi:10.1016/j.pmedr.2019.100884.
  • Sallam M, Ghazy RM, Al-Salahat K, Al-Mahzoum K, AlHadidi NM, Eid H, Kareem N, Al-Ajlouni E, Batarseh R, Ababneh NA, et al. The role of psychological factors and vaccine conspiracy beliefs in influenza vaccine hesitancy and uptake among Jordanian healthcare workers during the COVID-19 pandemic. Vaccines (Basel). 2022;10:1355. doi:10.3390/vaccines10081355.
  • Peretti-Watel P, Larson HJ, Ward JK, Schulz WS, Verger P. Vaccine hesitancy: clarifying a theoretical framework for an ambiguous notion. PLoS Curr. 2015;7. doi:10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289.